BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Passani MB, Blandina P, Torrealba F. The histamine H3 receptor and eating behavior. J Pharmacol Exp Ther 2011;336:24-9. [PMID: 20864503 DOI: 10.1124/jpet.110.171306] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Gao Z, Hurst WJ, Guillot E, Czechtizky W, Lukasczyk U, Nagorny R, Pruniaux MP, Schwink L, Sanchez JA, Stengelin S, Tang L, Winkler I, Hendrix JA, George PG. Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I). Bioorg Med Chem Lett 2013;23:3416-20. [PMID: 23591110 DOI: 10.1016/j.bmcl.2013.03.080] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
2 Van Laere KJ, Sanabria-Bohórquez SM, Mozley DP, Burns DH, Hamill TG, Van Hecken A, De Lepeleire I, Koole M, Bormans G, de Hoon J, Depré M, Cerchio K, Plalcza J, Han L, Renger J, Hargreaves RJ, Iannone R. (11)C-MK-8278 PET as a tool for pharmacodynamic brain occupancy of histamine 3 receptor inverse agonists. J Nucl Med 2014;55:65-72. [PMID: 24263088 DOI: 10.2967/jnumed.113.122515] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
3 Zendehdel M, Baghbanzadeh A, Aghelkohan P, Hassanpour S. Central histaminergic system interplay with suppressive effects of immune challenge on food intake in chicken. Br Poult Sci 2016;57:271-9. [PMID: 26924422 DOI: 10.1080/00071668.2016.1141173] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Ghamari N, Zarei O, Arias-Montaño JA, Reiner D, Dastmalchi S, Stark H, Hamzeh-Mivehroud M. Histamine H3 receptor antagonists/inverse agonists: Where do they go? Pharmacol Ther 2019;200:69-84. [PMID: 31028835 DOI: 10.1016/j.pharmthera.2019.04.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 7.0] [Reference Citation Analysis]
5 Gao Z, Hurst WJ, Czechtizky W, Hall D, Moindrot N, Nagorny R, Pichat P, Stefany D, Hendrix JA, George PG. Identification and profiling of 3,5-dimethyl-isoxazole-4-carboxylic acid [2-methyl-4-((2S,3′S)-2-methyl-[1,3′]bipyrrolidinyl-1′-yl)phenyl] amide as histamine H3 receptor antagonist for the treatment of depression. Bioorganic & Medicinal Chemistry Letters 2013;23:6269-73. [DOI: 10.1016/j.bmcl.2013.09.081] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
6 España RA, Scammell TE. Sleep neurobiology from a clinical perspective. Sleep 2011;34:845-58. [PMID: 21731134 DOI: 10.5665/SLEEP.1112] [Cited by in Crossref: 81] [Cited by in F6Publishing: 63] [Article Influence: 7.4] [Reference Citation Analysis]
7 He M, Deng C, Huang X. The Role of Hypothalamic H1 Receptor Antagonism in Antipsychotic-Induced Weight Gain. CNS Drugs 2013;27:423-34. [DOI: 10.1007/s40263-013-0062-1] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 6.3] [Reference Citation Analysis]
8 Frandsen IO, Boesgaard MW, Fidom K, Hauser AS, Isberg V, Bräuner-Osborne H, Wellendorph P, Gloriam DE. Identification of Histamine H3 Receptor Ligands Using a New Crystal Structure Fragment-based Method. Sci Rep 2017;7:4829. [PMID: 28684785 DOI: 10.1038/s41598-017-05058-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Gao Z, Hurst WJ, Guillot E, Nagorny R, Pruniaux M, Hendrix JA, George PG. Synthesis, characterization, and biological assessment of the four stereoisomers of the H3 receptor antagonist 5-fluoro-2-methyl-N-[2-methyl-4-(2-methyl[1,3′]bipyrrolidinyl-1′-yl)phenyl]benzamide. Bioorganic & Medicinal Chemistry Letters 2013;23:4044-7. [DOI: 10.1016/j.bmcl.2013.05.068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
10 Kim GW, Lin JE, Blomain ES, Waldman SA. New advances in models and strategies for developing anti-obesity drugs. Expert Opin Drug Discov 2013;8:655-71. [PMID: 23621300 DOI: 10.1517/17460441.2013.792804] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
11 Umehara H, Fabbri R, Provensi G, Passani MB. The hypophagic factor oleoylethanolamide differentially increases c-fos expression in appetite regulating centres in the brain of wild type and histamine deficient mice. Pharmacological Research 2016;113:100-7. [DOI: 10.1016/j.phrs.2016.08.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
12 Blandina P, Munari L, Provensi G, Passani MB. Histamine neurons in the tuberomamillary nucleus: a whole center or distinct subpopulations? Front Syst Neurosci 2012;6:33. [PMID: 22586376 DOI: 10.3389/fnsys.2012.00033] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 7.2] [Reference Citation Analysis]
13 Romano A, Tempesta B, Provensi G, Passani MB, Gaetani S. Central mechanisms mediating the hypophagic effects of oleoylethanolamide and N-acylphosphatidylethanolamines: different lipid signals? Front Pharmacol 2015;6:137. [PMID: 26167152 DOI: 10.3389/fphar.2015.00137] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
14 Logan J, Carruthers NI, Letavic MA, Sands S, Jiang X, Shea C, Muench L, Xu Y, Carter P, King P, Fowler JS. Blockade of the brain histamine H3 receptor by JNJ-39220675: preclinical PET studies with [¹¹C]GSK189254 in anesthetized baboon. Psychopharmacology (Berl) 2012;223:447-55. [PMID: 22614669 DOI: 10.1007/s00213-012-2733-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
15 Passani MB, Ballerini C. Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis. Front Syst Neurosci 2012;6:32. [PMID: 22563309 DOI: 10.3389/fnsys.2012.00032] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
16 Zamyad M, Abbasnejad M, Esmaeili-Mahani S, Sheibani V, Raoof M. Pain influences food preference and food-related memory by activating the basolateral amygdala in rats. Exp Brain Res 2021;239:79-93. [PMID: 33104830 DOI: 10.1007/s00221-020-05961-1] [Reference Citation Analysis]
17 Naganuma F, Nakamura T, Yoshikawa T, Iida T, Miura Y, Kárpáti A, Matsuzawa T, Yanai A, Mogi A, Mochizuki T, Okamura N, Yanai K. Histamine N-methyltransferase regulates aggression and the sleep-wake cycle. Sci Rep 2017;7:15899. [PMID: 29162912 DOI: 10.1038/s41598-017-16019-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
18 Ledneczki I, Tapolcsányi P, Gábor E, Éles J, Greiner I, Schmidt É, Némethy Z, Kedves RS, Balázs O, Román V, Lévay G, Mahó S. Discovery of novel steroidal histamine H3 receptor antagonists/inverse agonists. Bioorg Med Chem Lett 2017;27:4525-30. [PMID: 28888822 DOI: 10.1016/j.bmcl.2017.08.060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
19 Tabarean IV. Histamine receptor signaling in energy homeostasis. Neuropharmacology 2016;106:13-9. [PMID: 26107117 DOI: 10.1016/j.neuropharm.2015.04.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
20 Jaefari-anari M, Zendehdel M, Gilanpour H, Asghari A, Babapour V. Central Opioidergic System Interplay with Histamine on Food Intake in Neonatal Chicks: Role of µ-Opioid and H1/H3 Receptors. Braz J Poult Sci 2018;20:595-604. [DOI: 10.1590/1806-9061-2018-0785] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
21 Provensi G, Blandina P, Passani MB. The histaminergic system as a target for the prevention of obesity and metabolic syndrome. Neuropharmacology 2016;106:3-12. [PMID: 26164344 DOI: 10.1016/j.neuropharm.2015.07.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 4.4] [Reference Citation Analysis]
22 Chukwu J, Delanty N, Webb D, Cavalleri GL. Weight change, genetics and antiepileptic drugs. Expert Rev Clin Pharmacol 2014;7:43-51. [PMID: 24308788 DOI: 10.1586/17512433.2014.857599] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
23 Szczepańska K, Pockes S, Podlewska S, Höring C, Mika K, Latacz G, Bednarski M, Siwek A, Karcz T, Nagl M, Bresinsky M, Mönnich D, Seibel U, Kuder KJ, Kotańska M, Stark H, Elz S, Kieć-Kononowicz K. Structural modifications in the distal, regulatory region of histamine H3 receptor antagonists leading to the identification of a potent anti-obesity agent. Eur J Med Chem 2021;213:113041. [PMID: 33261900 DOI: 10.1016/j.ejmech.2020.113041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Panula P, Nuutinen S. The histaminergic network in the brain: basic organization and role in disease. Nat Rev Neurosci 2013;14:472-87. [DOI: 10.1038/nrn3526] [Cited by in Crossref: 179] [Cited by in F6Publishing: 168] [Article Influence: 19.9] [Reference Citation Analysis]
25 Passani MB, Blandina P. Histamine receptors in the CNS as targets for therapeutic intervention. Trends Pharmacol Sci 2011;32:242-9. [PMID: 21324537 DOI: 10.1016/j.tips.2011.01.003] [Cited by in Crossref: 130] [Cited by in F6Publishing: 127] [Article Influence: 11.8] [Reference Citation Analysis]
26 Mika K, Szafarz M, Bednarski M, Kuder K, Szczepańska K, Pociecha K, Pomierny B, Kieć-Kononowicz K, Sapa J, Kotańska M. Metabolic benefits of novel histamine H3 receptor ligands in the model of excessive eating: The importance of intrinsic activity and pharmacokinetic properties. Biomed Pharmacother 2021;142:111952. [PMID: 34325303 DOI: 10.1016/j.biopha.2021.111952] [Reference Citation Analysis]
27 Provensi G, Coccurello R, Umehara H, Munari L, Giacovazzo G, Galeotti N, Nosi D, Gaetani S, Romano A, Moles A, Blandina P, Passani MB. Satiety factor oleoylethanolamide recruits the brain histaminergic system to inhibit food intake. Proc Natl Acad Sci U S A 2014;111:11527-32. [PMID: 25049422 DOI: 10.1073/pnas.1322016111] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 7.5] [Reference Citation Analysis]
28 Laurino A, Gencarelli M, Raimondi L. The 3-iodothyronamine (T1AM) and the 3-iodothyroacetic acid (TA1) indicate a novel connection with the histamine system for neuroprotection. Eur J Pharmacol 2021;912:174606. [PMID: 34717926 DOI: 10.1016/j.ejphar.2021.174606] [Reference Citation Analysis]
29 Lian J, Huang X, Pai N, Deng C. Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications. Pharmacological Research 2016;106:51-63. [DOI: 10.1016/j.phrs.2016.02.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
30 Jackson VM, Price DA, Carpino PA. Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies. Expert Opinion on Investigational Drugs 2014;23:1055-66. [DOI: 10.1517/13543784.2014.918952] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
31 Purón-Sierra L, Miranda MI. Histaminergic modulation of cholinergic release from the nucleus basalis magnocellularis into insular cortex during taste aversive memory formation. PLoS One 2014;9:e91120. [PMID: 24625748 DOI: 10.1371/journal.pone.0091120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
32 Umehara H, Mizuguchi H, Fukui H. Identification of a histaminergic circuit in the caudal hypothalamus: an evidence for functional heterogeneity of histaminergic neurons. Neurochem Int 2012;61:942-7. [PMID: 22677810 DOI: 10.1016/j.neuint.2012.05.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
33 Yoshikawa T, Nakamura T, Yanai K. Histaminergic neurons in the tuberomammillary nucleus as a control centre for wakefulness. Br J Pharmacol 2021;178:750-69. [PMID: 32744724 DOI: 10.1111/bph.15220] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
34 Kumar A, Pasam VR, Thakur RK, Singh M, Singh K, Shukla M, Yadav A, Dogra S, Sona C, Umrao D, Jaiswal S, Ahmad H, Rashid M, Singh SK, Wahajuddin M, Dwivedi AK, Siddiqi MI, Lal J, Tripathi RP, Yadav PN. Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity. J Med Chem 2019;62:4638-55. [PMID: 30998358 DOI: 10.1021/acs.jmedchem.9b00241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Yousefvand S, Hamidi F. The Role of Ventromedial Hypothalamus Receptors in the Central Regulation of Food Intake. Int J Pept Res Ther 2021;27:689-702. [DOI: 10.1007/s10989-020-10120-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
36 Sihag J, Jones PJH. Oleoylethanolamide: The role of a bioactive lipid amide in modulating eating behaviour: Feeding behavioural physiology: OEA & obesity. Obesity Reviews 2018;19:178-97. [DOI: 10.1111/obr.12630] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
37 Wright KP, Lowry CA, Lebourgeois MK. Circadian and wakefulness-sleep modulation of cognition in humans. Front Mol Neurosci 2012;5:50. [PMID: 22529774 DOI: 10.3389/fnmol.2012.00050] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 8.2] [Reference Citation Analysis]
38 Velcicky J, Miltz W, Oberhauser B, Orain D, Vaupel A, Weigand K, Dawson King J, Littlewood-Evans A, Nash M, Feifel R, Loetscher P. Development of Selective, Orally Active GPR4 Antagonists with Modulatory Effects on Nociception, Inflammation, and Angiogenesis. J Med Chem 2017;60:3672-83. [PMID: 28445047 DOI: 10.1021/acs.jmedchem.6b01703] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
39 Kotańska M, Kuder KJ, Szczepańska K, Sapa J, Kieć-Kononowicz K. The histamine H3 receptor inverse agonist pitolisant reduces body weight in obese mice. Naunyn Schmiedebergs Arch Pharmacol 2018;391:875-81. [PMID: 29802412 DOI: 10.1007/s00210-018-1516-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
40 Heidarzadeh H, Zendehdel M, Babapour V, Gilanpour H. The effect of Nesfatin-1 on food intake in neonatal chicks: role of CRF1 /CRF2 and H1/ H3 receptors. Vet Res Commun 2018;42:39-47. [DOI: 10.1007/s11259-017-9706-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
41 Schlicker E, Kathmann M. Role of the Histamine H3 Receptor in the Central Nervous System. Handb Exp Pharmacol 2017;241:277-99. [PMID: 27787717 DOI: 10.1007/164_2016_12] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
42 Lee EY, Hwang YG, Lee HS. Hypothalamic neuronal origin of neuropeptide Y (NPY) or cocaine- and amphetamine-regulated transcript (CART) fibers projecting to the tuberomammillary nucleus of the rat. Brain Research 2017;1657:16-28. [DOI: 10.1016/j.brainres.2016.11.025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
43 Gao Z, Hurst WJ, Guillot E, Czechtizky W, Lukasczyk U, Nagorny R, Pruniaux M, Schwink L, Sanchez JA, Stengelin S, Tang L, Winkler I, Hendrix JA, George PG. Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (Part II). Bioorganic & Medicinal Chemistry Letters 2013;23:3421-6. [DOI: 10.1016/j.bmcl.2013.03.081] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
44 Provensi G, Passani MB, Costa A, Izquierdo I, Blandina P. Neuronal histamine and the memory of emotionally salient events. Br J Pharmacol 2020;177:557-69. [PMID: 30110713 DOI: 10.1111/bph.14476] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
45 Fell MJ, Flik G, Dijkman U, Folgering JH, Perry KW, Johnson BJ, Westerink BH, Svensson KA. Glutamatergic regulation of brain histamine neurons: In vivo microdialysis and electrophysiology studies in the rat. Neuropharmacology 2015;99:1-8. [DOI: 10.1016/j.neuropharm.2015.05.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
46 Perdan-pirkmajer K, Pirkmajer S, Černe K, Kržan M. Molecular and kinetic characterization of histamine transport into adult rat cultured astrocytes. Neurochemistry International 2012;61:415-22. [DOI: 10.1016/j.neuint.2012.05.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
47 Sandiego CM, Barret O, Lee H, Alagille D, Amenta A, Fowles K, Holden D, Seibyl JP, Tamagnan G. Imaging histamine H3 receptors with [18 F]FMH3: Test-retest and occupancy studies in the non-human primate. Synapse 2019;73:e22096. [PMID: 30835877 DOI: 10.1002/syn.22096] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Clapp RH, Luckman SM. Proxyfan acts as a neutral antagonist of histamine H3 receptors in the feeding-related hypothalamic ventromedial nucleus. Br J Pharmacol 2012;167:1099-110. [PMID: 22646302 DOI: 10.1111/j.1476-5381.2012.02056.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
49 Kotańska M, Mika K, Reguła K, Szczepańska K, Szafarz M, Bednarski M, Olejarz-maciej A, Nowak K, Latacz G, Mogilski S, Kuder KJ, Kieć-kononowicz K, Sapa J. KSK19 – Novel histamine H3 receptor ligand reduces body weight in diet induced obese mice. Biochemical Pharmacology 2019;168:193-203. [DOI: 10.1016/j.bcp.2019.07.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
50 Zwickl H, Zwickl-Traxler E, Pecherstorfer M. Is Neuronal Histamine Signaling Involved in Cancer Cachexia? Implications and Perspectives. Front Oncol 2019;9:1409. [PMID: 31921666 DOI: 10.3389/fonc.2019.01409] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]